欢迎来到 CSNpharm! 产品仅用于科研!
首页 Compound Arrays 促销产品
400-920-2911 sales@csnpharm.cn    

New Products

Cat. No. Product Name CAS No. Information
CSN24749 Qstatin  902688-24-8
CSN24753 AB928  2239273-34-6
CSN24767 CA-5f  1370032-19-1 CA-5f is identified as a potent late-stage macroautophagy/autophagy inhibitor via inhibiting autophagosome-lysosome fusion. It exhibted potential clin
CSN24771 ADH-503  2055362-74-6 ADH-503 is a potent agonist of the integrin CD11b to mitigate myeloid cell immunosuppression.
CSN24778 PH-002  1311174-68-1 PH-002 is an inhibitor of apolipoprotein (apo) E4 intramolecular domain interaction in neuronal cells that could rescue impairments of mitochondrial m
CSN24774 Mc-Val-Ala-PAB  1870916-87-2 Mc-Val-Ala-PAB is a useful ADC linker conjugating for targeting drug delivery.
CSN24773 Fmoc-Val-Ala-PAB  1394238-91-5 Fmoc-Val-Ala-PAB is a useful ADC linker conjugating for targeting drug delivery.
CSN24803 GNF4877  2041073-22-5 GNF4877 is a potent DYRK1A and GSK3β inhibitor with IC50s of 6 nM and 16 nM, respectively
CSN24782 Lotamilast  947620-48-6 Lotamilast (RVT-501; E6005) is a selective phosphodiesterase 4 (PDE4) inhibitor with an IC50 of 2.8 nM.
CSN24788 O-304  1261289-04-6 O-304 is a first-in-class, orally available pan-AMPK activator, which increases AMPK activity by suppressing the dephosphorylation of pAMPK. O-304 exh
CSN24797 AST2818 mesylate  2130958-55-1 AST2818 mesylate is an EGFR inhibitor.
CSN24794 JNJ-632  1572510-42-9 JNJ-632 is a hepatitis B virus (HBV) capsid assembly modulator (CAM).
CSN24801 TP353  1253799-29-9 TP353 is a CDK7 inhibitor.
CSN25213 MRTX1257  2206736-04-9 MRTX1257 is a selective, covalent K-Ras G12C inhibitor with oral activity in animal models of cancer.
CSN25222 CC-90011 besylate  2097523-60-7 CC-90011 is a potent and orally active LSD1 inhibitor. It is in phase I clinical study of CC-90011 in patients (pts) with advanced unresectable solid
CSN25223 PF-06882961  2230198-02-2 PF-06882961 is a potent and orally bioavailable GLP-1R agonist.
CSN25218 AT-007  2170729-29-8 AT-007 is a central nervous system (CNS) penetrant Aldose Reductase inhibitor (ARI) in Phase 1/2 development for treatment of Galactosemia.
CSN25217 GSK-25  874119-56-9 GSK-25 is a ROCK1 inhibitor with IC50 value of 6nM. It showed oral bioavailability (49% in rat and 19% in monkey), good half-life (1.8 h in rat and 2.
CSN25229 SBI-115  882366-16-7 SBI-115 is a GPBAR1 (TGR5) antagonist.
CSN25239 YAP-TEAD Inhibitor 1 TFA  1659305-79-9 YAP-TEAD Inhibitor 1 is an inhibitor of this YAP-TEAD protein-protein interaction which has potential usage in treatment of YAP-involved cancers with
CSN25240 Cl-amidine TFA  1043444-18-3 Cl-amidine is a peptidylarginine deminase (PAD) inhibitor, with an IC50 5.9±0.3 μM for PAD4.
CSN25244 Adenosine amine congener  96760-69-9 Adenosine amine congener hydrate is a potent aqueous-soluble A1 adenosine receptor agonist with Ki value of 0.85nM for binding against [3H]N6-cyclohex
CSN25246 PK11007  874146-69-7 PK11007 is mild thiol alkylator with anticancer activity in several cell lines, especially those with mutationally compromised p53.
CSN25251 CCG-222740  1922098-69-8 CCG-222740 is a Rho/MRTF pathway inhibitor. It decreases the activation of stellate cells in vitro and in vivo, by reducing the levels o
CSN25255 Emodepside  155030-63-0 Emodepside is an antiparasitic that is effective against a number of gastrointestinal nematodes, used in cat.
CSN25271 EC5026  1809885-32-2 EC5026 is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism
CSN25277 sb4  100874-08-6 sb4 is a potent BMP4 agonist.
CSN25282 Raphin1  2022961-17-5 Raphin1 was orally bioavailable, crossed the blood-brain barrier, and demonstrated efficacy in a mouse model of Huntington's disease. In cells, Raphi
CSN25292 Ibrolipim  133208-93-2 Ibrolipim is a Lipoprotein lipase activator.
CSN25290 PK150  2165324-62-7 PK150 is an analogue of Sorafenib, with oral bioavailability and antibacterial activity against several pathogenic strains at submicromolar concentrat
CSN25289 TLX agonist 1  958323-31-4 TLX agonist 1 (ccrp2) is an orphan nuclear receptor tailless (TLX, NR2E1) modulator with EC50 of 1μM and Kd of 650 nM.
CSN25293 ABT-724 3HCl  587870-77-7 ABT-724 3HCl is a potent and highly selective dopamine D4 receptor agonist with EC50s of 12.4 nM, 14.3 nM and 23.2 nM for human dopamine D4 receptor,
CSN25303 CCT128930 HCl  N/A CCT128930 is a potent ATP-competitive, selective Akt2 inhibitor with an IC50 of 6 nM and > 28-fold selectivity for Akt2 than the closely related PKA k
CSN25308 NEurotensin(8-13)  60482-95-3 Neurotensin Fragment 8-13 is the smallest active fragment of neurotensin which is a potent cellular mitogen for various colorectal and pancreatic canc
CSN25551 EIDD-2801  2349386-89-4 EIDD-2801 is an orally bioavailable prodrug of EIDD-1931, which has a broad-spectrum antiviral activity against 39 multiple coronaviruses, including S
CSN25566 Danicopan  1903768-17-1 Danicopan is selective and orally active small-molecule factor D inhibitor, shows high binding affinity to human Factor D with Kd value of 0.54 nM. It
CSN25632 CADD522  199735-88-1 CADD522 is a small molecule that inhibits the DNA binding of RUNX2. It negatively regulated transcription of RUNX2 target genes such as matrix metallo
CSN25635 OGG1 Inhibitor O8  350997-39-6 O8 OGG1 Inhibitor is an inhibitor of OGG1 with IC50 value of 0.35μM in fluorescence-based OGG1 assays. It can inhibit Schiff base formation during OGG
CSN25655 Mycro-3  944547-46-0 Mycro3 is a small-molecule inhibitor of Myc-Max dimerization. The average residual tumor of Pdx1-cre/KRAS* mice after Mycro3 treatment (100mg/kg, oral
CSN25872 MAC-545496  838810-96-1 MAC-545496 is a nanomolar inhibitor of GraR. It reverses β-lactam resistance in the community-acquired MRSA USA300 strain.
CSN25874 VLX600  327031-55-0 VLX600 is preferentially active against quiescent cells in colon cancer 3-D microtissues. VLX600 shows enhanced cytotoxic activity under conditions of
CSN26106 JCN037  2305154-31-6 JCN037 is a potent EGFR inhibitor with IC50 values of 2.49 nM, 3.95 nM and 4.48 nM for EGFR, p-wtEGFR and pEGFRvⅢ, respectively. It displayed potent a
CSN26157 Azd5904  618913-30-7 AZD5904 is a potent and irreversible MPO inhibitor with IC50 value of 140nM. Continuous subcutaneous AZD5904 infusion during the 2 week selectively bl
CSN26164 RA-9  919091-63-7 RA-9 is a cell permeable and potent inhibitor of the ubiquitin-proteasome system (UPS) that targets deubiquitinating enzymes (DUB) without affecting 2
CSN27187 NVP-2  1263373-43-8 NVP-2 is a potent and selective ATP-competitive CDK9 inhibitor with IC50 value of 0.5nM.
CSN27185 Col003  328565-16-8 Col003 is a cell penetrant, selective and potent inhibitor of the interaction of Hsp47 with collagen. Col003 is the cleavage product of AK778.It compe
CSN27196 BAY-885  2307249-33-6 BAY-885 is a highly potent and selective ERK5 inhibitor with IC50 value of 35nM.
CSN27227 STAT3-IN-1  2059952-75-7 STAT3-IN-1 (compound 7d) is an excellent, selective and orally active STAT3 inhibitor, with IC50 values of 1.82 μM and 2.14 μM in HT29 and MDA-MB 231
CSN27232 AMG 511  1253573-53-3 AMG 511 is a potent and orally available pan inhibitor of class I PI3Ks, with Kis of 4 nM, 6 nM, 2 nM and 1 nM for PI3Kα, β, δ and γ, respectively. AM
CSN27283 Orelabrutinib  1655504-04-3 Orelabrutinib is an irreversible inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity.
<< PREV 1 2 NEXT >>